Robotic surgery in ovarian cancer

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Minimally Invasive Surgical Techniques

Background:

• Ovarian cancer (OC) is a leading cause of cancer-related death in women.
• Complete cytoreduction and surgical staging are key goals in OC treatment.
• Laparotomy remains the standard, but minimally invasive surgery (MIS) is gaining traction.

Purpose of the Study:

• To review the role and techniques of MIS in ovarian cancer treatment.
• To discuss the advantages and disadvantages of MIS, particularly robotic surgery.
• To explore MIS applications in early-stage, advanced-stage, and recurrent OC.

Main Methods:

• Literature review of minimally invasive surgical approaches in ovarian cancer.
• Analysis of studies comparing MIS with traditional laparotomy.
• Focus on robotic surgery as a key MIS technique for OC.

Main Results:

• MIS shows promise in early-stage OC with high survival rates and improved quality of life.
• MIS is valuable in advanced OC for predicting optimal cytoreduction and identifying candidates for neoadjuvant chemotherapy.
• MIS is also applicable in interval debulking and secondary cytoreduction for recurrent OC.

Conclusions:

• MIS, including robotic surgery, is increasingly important in the multidisciplinary management of ovarian cancer.
• MIS offers benefits in staging, cytoreduction, and patient outcomes across different OC stages.
• Further research and adoption of MIS techniques can enhance ovarian cancer treatment paradigms.